Figure 1.
Patient disposition. aCohorts included patients enrolled in dose-escalation and safety-expansion populations. All doses (7–1400 mg) refer to INCAGN01949.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.